Drug Profile
BR 55
Alternative Names: BR-55; BR55 CEUSLatest Information Update: 09 Jan 2023
Price :
$50
*
At a glance
- Originator Bracco Diagnostics
- Class Contrast media; Diagnostic agents
- Mechanism of Action Image enhancers; Ultrasonography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Ovarian cancer; Pancreatic cancer
- Phase I/II Solid tumours
Most Recent Events
- 09 Jan 2023 Phase II development in Ovarian cancer (Diagnosis) is still ongoing USA (IV)
- 09 Jan 2023 Phase II development in Pancreatic cancer (Diagnosis) is still ongoing USA (IV)
- 09 Jan 2023 No development reported - Phase-II for Solid tumours (Diagnosis) in Italy (IV)